Showing results (241-250 of 367) with videos related to
Sort By:
Pageof 37
British Journal of Cancer|November 16, 2018
High-affinity CD16-polymorphism and Fc-engineered antibodies enable activity of CD16-chimeric antigen receptor-modified T cells for cancer therapyFelicitas Rataj, Severin J Jacobi, Stefan Stoiber, et al.Frontiers in Immunology|September 3, 2019
A Tridimensional Model for NK Cell-Mediated ADCC of Follicular LymphomaEmilie Decaup, Cédric Rossi, Pauline Gravelle, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 6, 2016
Liposomal Treatment of Experimental Arthritis Can Be Monitored Noninvasively with a Radiolabeled Anti-Fibroblast Activation Protein AntibodyTessa van der Geest, Peter Laverman, Danny Gerrits, et al.Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|November 8, 2024
Assessment of the concomitant action of XBD173 and interferon β in a mouse model of multiple sclerosis using infrared marker bandsKrongkarn Sirinukunwattana, Christian Klein, Paul F A Clarke, et al.Oncoimmunology|February 21, 2022
Dissecting the mechanism of cytokine release induced by T-cell engagers highlights the contribution of neutrophilsGabrielle Leclercq, Llucia Alberti Servera, Sabrina Danilin, et al.Scientific Reports|September 25, 2019
Biochemical and biophysical characterization of purified native CD20 alone and in complex with rituximab and obinutuzumabMorgane Agez, Elodie Desuzinges Mandon, Thomas Iwema, et al.Antibodies (Basel, Switzerland)|November 24, 2025
CEA-4-1BBL: CEACAM5-Targeted 4-1BB Ligand Fusion Proteins for Cis Co-Stimulation with CEA-TCBChristina Claus, Claudia Ferrara-Koller, Johannes Sam, et al.Oncotarget|August 28, 2020
Obinutuzumab (GA101) vs. rituximab significantly enhances cell death, antibody-dependent cytotoxicity and improves overall survival against CD20+ primary mediastinal B-cell lymphoma (PMBL) in a xenograft NOD-scid IL2Rgnull (NSG) mouse model: a potential targeted agent in the treatment of PMBLYaya Chu, Aradhana Awasthi, Sanghoon Lee, et al.Plos One|April 25, 2013
Crystal structure of an anti-Ang2 CrossFab demonstrates complete structural and functional integrity of the variable domainSebastian Fenn, Christian B Schiller, Julia J Griese, et al.Nature|May 24, 2023
Ångström-resolution fluorescence microscopySusanne C M Reinhardt, Luciano A Masullo, Isabelle Baudrexel, et al.Pageof 37